drugset / Trial / NCT00535470

An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides

NCT00535470

Phase 2 Completed 100 enrolled Yaupon Therapeutics
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy and safety of topical application of MCH 0.04% in a propylene glycol ointment (PG)in patients with stage I or IIA MF previously treated with MCH 0.02% in a PG or AP ointment who did not achieve a complete response.

Timeline

Start
2007-07
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject mechlorethamine Small molecule 0.04 % Topical

Indications